MARKET

CPIX

CPIX

Cumberland
NASDAQ

Real-time Quotes | Nasdaq Last Sale

2.830
+0.060
+2.17%
Closed 16:00 05/17 EDT
OPEN
2.780
PREV CLOSE
2.770
HIGH
2.880
LOW
2.770
VOLUME
59.51K
TURNOVER
--
52 WEEK HIGH
3.940
52 WEEK LOW
2.580
MARKET CAP
42.23M
P/E (TTM)
-6.5555
1D
5D
1M
3M
1Y
5Y
8-K: CUMBERLAND PHARMACEUTICALS INC
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ________________________________ FORM 8-K ________________________________ CURRENT...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 5d ago
NERV, UPST, ARRY and IOVA among after-hours movers
Gainers: [[NERV]] +34.5%. [[UPST]] +17.9%. [[SIEN]] +10.5%. [[CPIX]] +7.8%. [[SNDX]] +6.0%.Losers: [[ARRY]] -11.1%. [[GO]] -6.3%. [[IOVA]] -4.9%. [[LTRPA]] -4.9%. [[AXNX]] -4.5%.
Seekingalpha · 6d ago
BRIEF-Cumberland Pharmaceuticals Reports First Quarter 2021 Financial Results & Company Update
reuters.com · 6d ago
Cumberland: Q1 Earnings Insights
Shares of Cumberland (NASDAQ:CPIX) moved higher in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 600.00% over the past year to $0.07, which beat the estimate of ($0.07).
Benzinga · 6d ago
Cumberland Pharmaceuticals EPS beats by $0.14, beats on revenue
Cumberland Pharmaceuticals (CPIX): Q1 Non-GAAP EPS of $0.07 beats by $0.14; GAAP EPS of $0.01 beats by $0.14.Revenue of $10.54M (+26.5% Y/Y) beats by $2.04M.Shares +4.65%.Press Release
Seekingalpha · 6d ago
Cumberland Pharmaceuticals, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / May 11, 2021 / Cumberland Pharmaceuticals, Inc. (NASDAQ:CPIX) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 11, 2021 at 4:30 PM Eastern Time.
ACCESSWIRE · 6d ago
-- Earnings Flash (CPIX) CUMBERLAND PHARMACEUTICALS Posts Q1 Revenue $10.5M, vs. Street Est of $8.5M
MT Newswires · 6d ago
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10)
Benzinga · 6d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CPIX. Analyze the recent business situations of Cumberland through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CPIX stock price target is 8.50 with a high estimate of 8.50 and a low estimate of 8.50.
EPS
Institutional Holdings
Institutions: 40
Institutional Holdings: 3.41M
% Owned: 22.83%
Shares Outstanding: 14.92M
TypeInstitutionsShares
Increased
5
149.81K
New
4
24.38K
Decreased
5
658.82K
Sold Out
2
188.72K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.61%
Pharmaceuticals & Medical Research
+0.65%
Key Executives
Chairman/Chief Executive Officer/Director
A. Kazimi
Chief Financial Officer
Michael Bonner
Executive Vice President/Director
Martin Cearnal
Executive Vice President
Leo Pavliv
Chief Compliance Officer/Vice President
James Herman
Independent Director
Gordon Bernard
Independent Director
Joseph Galante
Independent Director
Jonathan Griggs
Independent Director
Joey Jacobs
Independent Director
James Jones
Independent Director
Kenneth Krogulski
Independent Director
Caroline Young
No Data
About CPIX
Cumberland Pharmaceuticals Inc. (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company's product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection and related duodenal ulcer disease; Vaprisol (conivaptan) Injection to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; Hepatoren (ifetroban) Injection, and Boxaban (ifetroban) oral capsules for the treatment of patients with aspirin-exacerbated respiratory disease (AERD).

Webull offers kinds of Cumberland Pharmaceuticals, Inc. stock information, including NASDAQ:CPIX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CPIX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CPIX stock methods without spending real money on the virtual paper trading platform.